Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borrie P. Type 3 hyperlipoproteinaemia. Br Med J. 1969 Jun 14;2(5658):665–667. doi: 10.1136/bmj.2.5658.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Jan 5;276(1):34–contd. doi: 10.1056/NEJM196701052760107. [DOI] [PubMed] [Google Scholar]
- HARRIS-JONES J. N., JONES E. G., WELLS P. G. Xanthomatosis and essential hypercholesterolaemia. Lancet. 1957 Apr 27;272(6974):855–857. doi: 10.1016/s0140-6736(57)91390-9. [DOI] [PubMed] [Google Scholar]
- Jensen J., Blankenhorn D. H., Kornerup V. Blood-uric-acid levels in familial hypercholesterolaemia. Lancet. 1966 Feb 5;1(7432):298–300. doi: 10.1016/s0140-6736(66)90645-3. [DOI] [PubMed] [Google Scholar]
- Khachadurian A. K. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum. 1968 Jun;11(3):385–393. doi: 10.1002/art.1780110303. [DOI] [PubMed] [Google Scholar]
- Trevaks G., Lovell R. R. Effect of atromid and its components on uric acid excretion and on gout. Ann Rheum Dis. 1965 Nov;24(6):572–575. doi: 10.1136/ard.24.6.572. [DOI] [PMC free article] [PubMed] [Google Scholar]